1. Cramer CT, et al. Effects of a novel dual lipid synthesis inhibitor and its potential utility in treating dyslipidemia and metabolic syndrome. J Lipid Res 2004;45:1289–301.
2. Di Minno A, et al. Efficacy and safety of bempedoic acid in patients with hypercholesterolemia: systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc July 21, 2020; https://doi.org/10.1161/JAHA.119.016262.
3. Ference BA, et al. Mendelian randomization study of ACLY and cardiovascular disease. N Engl J Med 2019;380:1033–42.
Prof. Dr. med. Frank Lammert, Klinik für Innere Medizin II, Universitätsklinikum des Saarlandes, Kirrberger Straße 1, 66421 Homburg E-Mail: firstname.lastname@example.org